Sequenom (SQNM) Pressures into JPMorgan Presentation
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Join SI Premium – FREE
Sequenom (Nasdaq: SQNM) shares are looking a little pressured on volume today heading into a presentation at the J.P. Morgan Healthcare Conference this morning.
Chairman and CEO Harry F. Hixson, Jr., Ph.D, and Ronald M. Lindsay, Ph.D., Director and EVP of Strategic Planning, will be making the presentation, which is expected to start at 2:30pm EST.
Sequenom issued preliminary 2012 results last Sunday, seeing revenue topping expectations. To download Sequenom's January 2013 update, click here.
Shares are down over six percent Wednesday on heavy volume.
Chairman and CEO Harry F. Hixson, Jr., Ph.D, and Ronald M. Lindsay, Ph.D., Director and EVP of Strategic Planning, will be making the presentation, which is expected to start at 2:30pm EST.
Sequenom issued preliminary 2012 results last Sunday, seeing revenue topping expectations. To download Sequenom's January 2013 update, click here.
Shares are down over six percent Wednesday on heavy volume.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nutrabolt picks banks for IPO that could raise up to $1 billion - Reuters
- Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
- Michael Burry Says He Shorted Caterpillar For The First Time - Bloomberg
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
